Premium

Alternative Insight and Premium Journalism

Latest Articles

For Members Only

With a Thin IPO Calendar, Hedge Funds Are Zeroing In on Biopharma

Stephen Taub January 29, 2026

For Members Only

The Tiger Grandcub Who Outsmarted the AI Frenzy

Stephen Taub January 28, 2026

For Members Only

The Lowdown on High Ground’s Best Year

Stephen Taub January 26, 2026

For Members Only

Robert Citrone’s Discovery Capital Scores a Three‑Year Run of Outsized Returns

Stephen Taub January 22, 2026

For Members Only

How Electron Is Rewiring Its Portfolio This Year After a Muted Finish to 2025

Stephen Taub January 20, 2026

For Members Only

CTA Performance Splinters As a Late Surge Lifts Some, But Not All

Stephen Taub January 15, 2026

For Members Only

From Deep Losses to Remarkable Gains: Biopharma’s Wildest Year in Recent Memory

Stephen Taub January 14, 2026

For Members Only

Caxton and Graham Post Solid Gains in a Strong Year for Macro Funds

Stephen Taub January 13, 2026

For Members Only

Valiant Topped the Tiger Crowd in 2025

Stephen Taub January 12, 2026

For Members Only

Jericho’s Three-Year Hot Streak Shows No Signs of Cooling

Stephen Taub January 7, 2026

For Members Only

Light Street Caps Big Year After Dialing Back Chip Bets

Stephen Taub January 6, 2026

For Members Only

Four Months of Gains Couldn’t Save Greenlight’s Year

Stephen Taub January 5, 2026

For Members Only

Hedge Funds Miss 2025’s Biggest Stock Surges

Stephen Taub December 17, 2025

For Members Only

Biopharma Specialist Cormorant Plans New $125 Million Blank-Check Venture

Stephen Taub December 16, 2025

For Members Only

Hedge Funds Hope to Cash In on Perceptive Advisors’ SPAC

Stephen Taub December 15, 2025

For Members Only

Ex-TCI Partner Edgar Allen’s High Ground Racks Up Record Year

Stephen Taub December 9, 2025

For Members Only

Renaissance’s Public Funds Stage Double-Digit Comeback in November

Stephen Taub December 8, 2025

For Members Only

RA Capital Doubles Down on Private Deals as Year-End Frenzy Builds

Stephen Taub December 2, 2025

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2026 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

4.19.01 build:2026-04-14 Login